Compare RZLT & TLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RZLT | TLS |
|---|---|---|
| Founded | 2010 | 1969 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 321.6M | 358.4M |
| IPO Year | 2011 | 2020 |
| Metric | RZLT | TLS |
|---|---|---|
| Price | $4.25 | $4.10 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 5 |
| Target Price | ★ $9.67 | $7.90 |
| AVG Volume (30 Days) | ★ 1.5M | 858.1K |
| Earning Date | 05-13-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 26.32 | ★ 31.51 |
| EPS | N/A | ★ 0.03 |
| Revenue | N/A | ★ $164,805,000.00 |
| Revenue This Year | N/A | $18.72 |
| Revenue Next Year | N/A | $14.62 |
| P/E Ratio | ★ N/A | $148.67 |
| Revenue Growth | N/A | ★ 52.21 |
| 52 Week Low | $1.07 | $2.37 |
| 52 Week High | $11.46 | $8.36 |
| Indicator | RZLT | TLS |
|---|---|---|
| Relative Strength Index (RSI) | 68.45 | 40.34 |
| Support Level | $2.91 | $3.88 |
| Resistance Level | $9.80 | $4.65 |
| Average True Range (ATR) | 0.32 | 0.34 |
| MACD | 0.13 | -0.05 |
| Stochastic Oscillator | 77.60 | 0.00 |
Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases. The company aims to address unmet medical needs in conditions like congenital hyperinsulinism, a rare endocrine disorder causing excessive insulin production and resulting hypoglycemia. Rezolute's pipeline includes drug candidates designed to improve patient outcomes while reducing treatment burdens. The company engages in research, development, and clinical trials to advance its therapies and collaborates with medical communities and patient groups to support its objectives. Revenue and value creation depend largely on successful product development and regulatory approvals.
Telos Corp offers technology solutions and services that empower and protect the world's security-conscious organizations. The company delivers efficient, adaptable, and secure solutions that protect people, organizations, and information across government and industry. The company conducts its business through two reportable and operating segments: Security Solutions and Secure Networks. The Security Solutions segment is focused on cybersecurity, cloud, and identity solutions, and secure messaging through Xacta, Telos AMHS, and Telos ID offerings. The Secure Networks segment provides secure networking architectures and solutions to customers through secure mobility solutions, network management, and defense services. The majority of revenue is from Secure Networks.